Equity Gap
Capital Business Centre 24 Canning Street, Edinburgh, EH3 8EG, United Kingdom
Overview
Equity Gap is a group of private individuals set up to invest in and support emerging and growing businesses. The group are particularly interested in assisting young companies that have achieved the SMART award and businesses that have gone through a pre investment commercialisation process. They will consider other high growth companies but they must demonstrate a strong market and a clear investment exit strategy. Companies that Equity Gap invest in will be provided with ongoing business expertise and continuing support. Funding will typically be between £20,000 and £500,000. Where possible this will all be from Equity Gap, however they may work with other syndicates and Scottish Enterprise Co-Investment Fund to achieve the required funds. They meet once per month in central Edinburgh. At the meetings they usually have 2 presentations from companies, discuss current investments and review plans that they have received and circulated in the past month.
- Total investments
- 38
- Lead investments
- 14
- Investments · 12mo
- 3
- Active investors
- 3
Sector focus
- Finance
- Financial Services
Investment portfolio
- Lentitek
Led · Equity · Aug 2026
Lentitek develops enabling technologies aimed at improving the manufacturability and quality of cell and gene therapies, with a particular focus on supporting next‑generation in‑vivo CAR‑T treatments. The company says interest in its solutions has been driven by therapies moving from lab to clinic where quality is critical. Over the past year Lentitek transitioned from R&D to revenue-generating and signed several significant deals while building a larger commercial pipeline. Management positions the business to capitalise on demand for capabilities that aid manufacturability and quality in advanced therapies. Financially, Lentitek completed an equity raise of £725,000 led by Equity Gap and is conducting an ongoing fundraising process to provide working capital to convert its pipeline. The company characterized the funding as strengthening its finances to accelerate commercialisation.
- QuickBlock
Led · Equity · Jul 2026
QuickBlock develops defence infrastructure products, including rapid-deployment shelter solutions, and is investing in R&D to advance those offerings. The recent financing includes grant support earmarked for R&D activity related to its rapid deployment shelters. Management plans to use the funds to expand into key European markets, boost production capacity, and strengthen commercial capabilities. The company’s capital raise combined equity investment and innovation grants, indicating simultaneous focus on commercialization and technology development. No revenue, user, founding year, or location details were provided in the article.
- Gutsy Health
Participated · Equity · Dec 2025
Gutsy Health develops the Gut Wealth line of liquid and capsule supplements that combine a clinically studied, shelf-stable postbiotic with targeted vitamins and minerals to promote bowel regularity and calmer digestion. Founded by Scottish entrepreneur Gemma Stuart after her 15-year struggle with IBS, the company positions its products as simple, evidence-backed alternatives to trend-driven remedies. The brand has already garnered industry recognition, winning a Scottish EDGE Award and the UK StartUp Award for MedTech & HealthTech of the Year, and is reportedly helping "thousands of people" manage uncomfortable gut symptoms. With its new capital, Gutsy Health plans to expand beyond its core direct-to-consumer channel into pharmacies, health stores and national retailers while accelerating e-commerce growth on platforms such as Amazon. The company will also invest in new product development, including a lighter, easier-to-store capsule formulation, and aims to enter international markets by 2026. Financially, the business is still in its early stages and has not disclosed revenue figures, but the recent funding underscores investor confidence in its science-based approach and growth trajectory.
- Vector Photonics
Participated · Equity · Jun 2024
Vector Photonics develops unique surface-emitting laser technologies and is focused on commercialising those platforms. The company is advancing free-space optics and GaN material processing to enable blue and green lasers. It received equity and grant funding to provide a stronger financial base for continued development and commercialisation. The equity investment of £1.667M was provided by four prior investors: Foresight WAE Technology (FWT) Funds, UK Innovation & Science Seed Fund (UKI2S), Equity Gap and Scottish Enterprise. Additional research funding of £1.27M comprises two development projects: FRONTIERS (£670k, SBRI-funded, revenue-generating project for free-space optics) and GRAPHICS (£600k, Innovate UK grant in collaboration with the University of Glasgow). The GRAPHICS work could lead to blue and green lasers that consume about 70% less power than equivalent LEDs. Vector Photonics develops a new class of lasers (PCSELs) that aim to combine high speed, high power and low-cost manufacture. The company is commercialising these lasers to innovate laser manufacture and performance. Its first product is being developed to target datacentre networks. Vector is a spin-out from the University of Glasgow and was formed in 2020. Neil Martin leads the company as CEO. The business recently secured growth funding to support commercial development.
- Ulemco
Participated · Equity · May 2024
ULEMCo focuses on creating technologies that cut carbon emissions from vehicles which are traditionally challenging to decarbonise, such as heavy-duty or specialist transport applications. Its core product portfolio targets the replacement or reduction of fossil-based fuels in these vehicles, helping fleet operators meet stringent emissions targets. The company’s approach centers on accelerating real-world deployment of low-carbon solutions in transportation. ULEMCo’s latest funding indicates growing traction for its strategy to address hard-to-electrify segments of the market. Although detailed operating metrics were not disclosed, the new capital inflow highlights investor and governmental confidence in its technology roadmap. With fresh funds, the company plans to scale development and commercial deployment of its decarbonisation solutions.